Amphastar Pharmaceuticals (AMPH) Return on Invested Capital (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Return on Invested Capital of 0.26% for Q1 2026, down 124.0% year-over-year from 1.09% in Q1 2025, and down 42.72% quarter-over-quarter from 0.46% in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Return on Invested Capital (2014 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Return on Invested Capital history runs 13 years deep, the most recent figure standing at 0.26% for Q1 2026.
- In Q1 2026, Return on Invested Capital fell 124.0% year-over-year to 0.26%; the TTM figure through Mar 2026 stood at 0.26% (down 124.0% YoY), while the FY2025 annual figure was 1.47%, down 370.0% from the prior year.
- Return on Invested Capital for Q1 2026 stood at 0.26%, down from 0.46% in the prior quarter.
- The five-year high for Return on Invested Capital was 1.5% in Q1 2025, with the low at 6.51% in Q3 2024.
- The 5-year median for Return on Invested Capital is 0.1% (2022), against an average of 0.08%.
- The sharpest annual moves came in 2024 and 2025: Return on Invested Capital sank 659 bps in 2024, then surged 714 bps in 2025.
- Amphastar Pharmaceuticals' Return on Invested Capital stood at 0.1% in 2022, then soared by 355 bps to 0.46% in 2023, then jumped by 199 bps to 1.37% in 2024, then sank by 67 bps to 0.46% in 2025, then sank by 43 bps to 0.26% in 2026.
- Business Quant data shows AMPH's Return on Invested Capital at 0.26% in Q1 2026, 0.46% in Q4 2025, and 0.63% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 943.15 Mn | 653.02 Mn | 93.47 Mn | 0.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.15% |
| Mar 31, 2026 | 0.26% |
| Dec 31, 2025 | 0.46% |
| Sep 30, 2025 | 0.63% |
| Jun 30, 2025 | 1.16% |
| Mar 31, 2025 | 1.50% |
| Dec 31, 2024 | 1.37% |
| Sep 30, 2024 | -6.51% |
| Jun 30, 2024 | -0.19% |
| Mar 31, 2024 | -0.95% |
| Dec 31, 2023 | 0.46% |
| Sep 30, 2023 | 0.08% |
| Jun 30, 2023 | 0.07% |
| Mar 31, 2023 | 0.10% |
| Dec 31, 2022 | 0.10% |
| Sep 30, 2022 | 0.09% |
| Jun 30, 2022 | 0.07% |
| Mar 31, 2022 | 0.03% |
| Dec 31, 2021 | 0.02% |
| Sep 30, 2021 | 0.01% |